Recent Articles from Business Wire

American Express Global Business Travel, which is operated by Global Business Travel Group, Inc. (NYSE: GBTG) (“Amex GBT” or the “Company”), a leading software and services company for travel, expense, and meetings & events, today announced its board of directors has increased the capacity of the Company’s existing share repurchase program to $600 million, an increase of $300 million. The authorization reflects confidence in Amex GBT’s ability to deliver growth, AI-enabled product innovation, margin expansion and cash generation while maintaining a strong balance sheet and delivering attractive capital returns to shareholders.

Marriott Vacations Worldwide (NYSE: VAC) (“MVW,” the “Company,” “we,” “us” or “our”) today announced that its Board of Directors (the “Board”) has appointed Matthew (Matt) E. Avril as Chief Executive Officer. Mr. Avril will continue to serve as a member of the Board. Mr. Avril joined the Company’s Board in March 2025 and has served as interim President and CEO since November 2025.

Palliser Capital (“Palliser”), a top 20 shareholder of TOTO Ltd. (“TOTO”), today published a comprehensive presentation outlining the opportunities available to unlock significant value at TOTO. To promote market transparency and respond to growing interest from shareholders and other stakeholders, Palliser has made public a detailed presentation titled “Maximizing the Value of TOTO – The Most Undervalued and Overlooked AI Memory Beneficiary.” The presentation sets out Palliser’s assessment of TOTO’s unique strategic positioning, structural undervaluation, and the tangible steps required to drive a re‑rating of the company’s equity, with TOTO currently trading at a JPY554 billion (US$3.6 billion) value gap1.

IHS Mauritius BR Limited, part of IHS Holding Limited (NYSE: IHS) (“IHS Towers” or the “Company”), one of the largest independent owners, operators and developers of shared communications infrastructure in the world by tower count, has agreed to sell its Latin America tower operations (“IHS Latam”), inclusive of IHS Brazil1 and IHS Colombia and its approximately 8,8602 sites to Macquarie Asset Management (the “Latam Tower transaction”).

Omeros Corporation (NASDAQ: OMER) today announced the successful completion of its initial study in nonhuman primates evaluating the efficacy and safety of its OncotoX-AML cancer therapeutic platform. Omeros’ OncotoX-AML therapeutic is first targeting acute myeloid leukemia (AML), an aggressive and highly fatal bone marrow and blood cancer. The effectiveness of current AML treatments, such as chemotherapeutics and antibody-drug conjugates, are limited by substantial side effects. Administration of only one course of OncotoX-AML treatment to immunocompetent primates demonstrated the desired pharmacologic response, specifically marked, selective, reversible, and dose-related reduction in myeloid progenitor cells — the cells that can mutate and lead to AML — by up to 99 percent. OncotoX-AML was well tolerated, without causing broader or lasting hematologic changes while preserving hematopoietic stem cells. There were no observed safety signals or meaningful changes in blood chemistry values often seen with current AML treatments.

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced the publication of a peer-reviewed study in EP Europace evaluating vMap-guided activation mapping and ablation in patients with hemodynamically unstable ventricular tachycardia (VT).

New research from Conduent Incorporated (Nasdaq: CNDT), a global technology-driven business solutions and services company, highlights the tension HR teams face as they modernize operations, adopting AI and automation while still delivering the human connection employees value. These findings build on Conduent’s 2023 survey exploring employee satisfaction and HR engagement.

Central Garden & Pet Company (NASDAQ: CENT) (NASDAQ: CENTA), a leading consumer goods company in the pet and garden industries, announced today that its Board of Directors has authorized an increase in its stock repurchase program. Under the increased program, the company is authorized to purchase up to an additional $100 million of the company’s common stock and Class A common stock. The company stated that the acquisition of the company’s common stock at this time appeared to be advantageous to the company and its stockholders because management considers the market price of its shares to be currently undervalued.

NetXD, an innovative provider of cloud-native payment hub technology, today announced it has been positioned as a Visionary in the 2026 Gartner® Magic Quadrant™ for Banking Payment Hub Platforms, published on January 20, 2026.

NextGen Healthcare, a leading provider of innovative, cloud-based healthcare technology solutions, has been selected as a healthcare technology partner by Ohio ENT & Allergy Physicians. A range of solutions from NextGen Healthcare will optimize clinical, practice management, and revenue cycle workflows, creating a seamless NextGen® Closed Loop™ experience that improves the provider, staff, and patient journeys.

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO) (“Cardio Diagnostics” or the “Company”), a precision cardiovascular medicine company leveraging epigenetics, genetics, and artificial intelligence for the prevention and detection of cardiovascular disease, today announced that it will host an investor conference call on Wednesday, February 18, 2026, at 3 p.m. Central Time.

MaxLinear, Inc. (Nasdaq: MXL), a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits, today announced the appointment of Kris Sennesael to its Board of Directors, effective February 13, 2026.

DGeo, Labelmaster’s Dangerous Goods (DG) Packaging, Technology and Services Division, today announced the expansion of its packaging portfolio with the addition of UN-certified kits featuring Ardagh glass bottles for the shipping and storage of chemical liquids.

Arizona Sonoran Copper Company Inc. (TSX:ASCU | OTCQX:ASCUF) (“ASCU” or the “Company”) today announces that ASCU and Nuton LLC (“Nuton”), a Rio Tinto Venture, have mutually agreed to the early termination of the Option to Joint Venture (“OTJV”) on the Cactus Project, as well as the termination of Nuton’s investor rights agreement with the Company, effective immediately.

Newton Golf Company (NASDAQ: NWTG), a technology-forward golf equipment innovator applying physics-driven engineering to golf performance, has appointed John Bode to its board of directors. The appointment increases the board to five members, with three serving as independent directors.

Nakamoto Inc. (NASDAQ: NAKA) (“Nakamoto” or the “Company”) today announced that it has entered into merger agreements to acquire BTC Inc, the leading provider of Bitcoin-related media and events, and UTXO Management GP, LLC (“UTXO”), an investment firm focused on private and public Bitcoin companies (collectively, the “Transaction”). The Transaction is expected to close in the first quarter of 2026, subject to customary closing conditions.

Sea Limited (NYSE: SE) (“Sea” or the “Company”) plans to announce its fourth quarter and full year 2025 results before the U.S. market opens on March 3, 2026, U.S. Eastern Time.

OSI Systems, Inc. (NASDAQ: OSIS), today announced that it will be presenting at the Citi 2026 Global Industrial Tech and Mobility Conference on Thursday, February 19, 2026 at 1:00 PM ET.

Empery Digital Inc. (NASDAQ: EMPD) (the “Company” or “Empery Digital”) today announced an update on its previously authorized share repurchase program.

Bragg Gaming Group (NASDAQ: BRAG, TSX: BRAG) (“Bragg” or the “Company”), today announced a strategic partnership with Super Technologies (“Super”), a leading global entertainment technology company which also operates Sports betting and iGaming brands, to provide Bragg’s full suite of content aggregation and delivery services. This agreement will see Bragg become a key execution partner, delivering a stable, scalable content operation across Super Technologies' multi-brand, multi-jurisdictional portfolio.

CyberBay Summit 2026 returns to Tampa Bay on March 12–13 at the JW Marriott Tampa Water Street, convening leaders from government, industry, academia, and venture capital around one of the country’s most compelling cybersecurity stories.

Jabil Inc. (NYSE: JBL) today released its Fiscal Year 2025 Sustainability Progress Report, detailing the company’s achievements during year four of its five-year sustainability strategy. The report highlights Jabil’s progress toward greenhouse gas reduction, diverting waste from landfills, and giving back to local communities.

Booz Allen Hamilton (NYSE: BAH) today announced that it has entered into a definitive agreement to acquire Defy Security as a wholly owned subsidiary. Together, Defy Security and Booz Allen’s global commercial business will deliver end-to-end, tech-enabled cybersecurity solutions and products for U.S. and international enterprises in financial services, health and life sciences, manufacturing, technology, energy, retail, and beyond.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced details of new clinical and real-world data from its innovative HIV treatment and prevention portfolio and research pipeline that will be presented at the 33rd Conference on Retroviruses and Opportunistic Infections (CROI 2026) being held from February 22-25 in Denver, Colorado. Focusing on expanding therapeutic options to meet the diverse needs of communities affected by HIV, notable late-breaking abstracts include Phase 3 results from the ARTISTRY-1 and ARTISTRY-2 trials that explored the efficacy and safety of an investigational, single-tablet combination regimen of bictegravir and lenacapavir for HIV treatment.

The Prostate Cancer Foundation (PCF) today announced $6.3 million in funding for 31 exceptional Young Investigators pursuing groundbreaking discoveries in prostate cancer. Since 1993, PCF’s prestigious early-career awards program has identified and supported the world’s brightest emerging researchers, providing critical funding and mentorship to accelerate clinical innovation and patient care.

BlackSky Technology Inc. (NYSE: BKSY) secured a new eight-figure international contract for accelerated delivery of a Gen-3 sovereign space-based intelligence solution. The agreement combines the sale of one Gen-3 very-high resolution 35-centimeter satellite with recurring, multi-year on-orbit operations and subscription-based Assured imagery and analytics services, leveraging the company’s fully automated end-to-end architecture enabled by the BlackSky Spectra® software platform and its ground network to deliver real-time insights at mission speed and scale.

Everbridge, Inc., the global leader in High Velocity Critical Event Management (CEM) and national public warning solutions, today shared a first look at the Discover Resilience 2026 agenda, including newly announced keynote speakers and featured sessions at the company’s annual customer conference, taking place April 19–22, 2026, in Chicago.

Qlik®, a data integration, data quality, analytics, and AI company, today announced its recognition as a Leader in the 2026 Gartner® Magic Quadrant for Augmented Data Quality Solutions, marking its seventh time receiving this recognition. Qlik sees this recognition as validation of its commitment to helping businesses ensure the data quality and governance needed to drive AI confidently at scale.

Marchex® (NASDAQ: MCHX), which harnesses the power of AI and conversation intelligence to provide actionable insights derived from prescriptive vertical-market data analytics, today announced that one of North America’s largest auto repair service providers has agreed to expand its use of Marchex’s AI-driven solutions, making them available at several hundred North American-based franchise locations.

BTIG announced today that Owen Bennett has joined the firm as Managing Director and Consumer Staples Analyst, focusing on the tobacco and beverage sectors. "We are thrilled to welcome Owen to BTIG. His extensive expertise in the tobacco space, coupled with deep industry relationships and a differentiated research approach, will enhance our consumer sector coverage and broaden the insights we offer to clients," said Ryan Serwin, CFA, BTIG's Director of Research. "Owen’s arrival underscores BTIG’s focus on advancing its sector coverage through the recruitment of experts with proven track records.”

The Office of the Alabama Attorney General, the Alabama Anti-Human Trafficking Alliance, and The WellHouse today announced the public release of the Alabama Statewide Human Trafficking Assessment at the Alabama Human Trafficking Summit. Developed in partnership with Engage Together®, the assessment marks the completion of Phase 1: Research & Reports—a comprehensive, data-driven analysis designed to strengthen efforts to prevent and combat human trafficking across every county in Alabama.

LiveRamp (NYSE: RAMP), the leading data collaboration network, today announced that Kristi Argyilan has been appointed to the Company’s Board of Directors.

Wave Function Ventures® announces a strategic investment in Natilus, a San Diego-based aerospace company developing blended-wing-body (BWB) aircraft designed to transform cargo and passenger aviation through significantly improved efficiency and reduced emissions.

Corpay, Inc.*, (NYSE: CPAY) a global leader in corporate payments, today announced that its Cross-Border business has entered into an agreement with Pramac Racing Limited, one of the most innovative teams competing in the MotoGP World Championship. Under the agreement, Corpay becomes Pramac Racing’s Official Commercial Foreign Exchange (FX) Partner and a Premium Partner of the team.

Investors Title Company (Nasdaq: ITIC) today announced results for the fourth quarter ended December 31, 2025. The Company reported net income of $7.5 million, or $3.97 per diluted share, compared to $8.4 million, or $4.41 per diluted share, for the prior year period.

Halper Sadeh LLC, an investor rights law firm, is investigating the merger of VerifyMe, Inc. (NASDAQ: VRME) and Open World Ltd.

PAX, a pioneering global cannabis brand, today announced its anticipated return to the Canadian market with the launch of TRIP, PAX’s All-in-One vaporizer in the brand’s award-winning Live Rosin with Diamonds line. Products are now available in Ontario, Manitoba and Saskatchewan, with further expansion to come.

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Kennedy-Wilson Holdings, Inc. (NYSE: KW) to a consortium led by William McMorrow, Chairman and Chief Executive Officer of Kennedy-Wilson, and certain other senior executives of Kennedy-Wilson, together with Fairfax Financial Holdings Limited, for $10.90 per share in cash.

Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with semiconductor chip-based ultrasound devices, software and AI, today announced that it will participate at the TD Cowen 46th Annual Health Care Conference in Boston on March 3, 2026. Joseph DeVivo, President, Chief Executive Officer & Chairman; John Doherty, EVP, Chief Financial Officer; and Megan Carlson, SVP, Accounting & Finance – Chief Accounting Officer, will present and host one-on-one investor meetings. The company presentation will occur at 11:50 AM ET on March 3.

Boyd is excited to announce its growing capacity for AI data center liquid cooling system production with the expansion of its design and manufacturing facility in Juarez, Mexico. To scale with growing hyperscaler, colocation, and enterprise AI data center installation demand, Boyd’s Juarez thermal campus is being expanded to approximately 460,000 square feet, up from its current footprint of 217,000 square feet.

Harmony Biosciences (Nasdaq: HRMY) today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental new drug application (sNDA) for WAKIX® (pitolisant) tablets for the treatment of cataplexy in pediatric patients 6 years of age and older with narcolepsy. WAKIX is now the first-and-only FDA-approved non-scheduled treatment for pediatric and adult narcolepsy patients with or without cataplexy.

Ameresco, Inc., (NYSE: AMRC), a leading energy infrastructure solutions provider, and Luminace, one of the largest decarbonization-as-a-service providers in North America, jointly announced the successful completion of the Coventry Landfill Solar project. This milestone marks a significant advancement in the Town of Coventry’s efforts to expand renewable energy generation and enhance long‑term environmental stewardship.

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of TOTAL30® Multifocal for Astigmatism, the world’s only multifocal toric contact lens with Water Gradient Technology, helping patients stay in lenses comfortably,† as their vision changes from standard correction to age-related presbyopia.1 These lenses provide excellent end-of-day comfort with wearers rating nearly 8/10, even on day 30, providing patients clear, seamless and stable vision at all distances, near through far.1 The lenses are now available across the U.S., enabling Eye Care Professionals (ECPs) to offer them to patients nationwide.

Aya Healthcare, the nation’s largest healthcare workforce solutions technology and staffing company, is building momentum in 2026 by showcasing the continued impact of its Technology Advisory Board (TAB), whose expertise is accelerating innovation and redefining the future of healthcare workforce technology. As the industry leader in workforce solutions for 25 years, Aya partners with thousands of healthcare organizations nationwide, combining powerful technology with experienced teams to strengthen their workforce and serve their communities with confidence.

Guardsquare, the leading provider of mobile application security, today released its analysis of new independent research conducted by TrendCandy, revealing a widening “client-side trust gap” that is leaving organizations exposed to mobile app security incidents, customer churn, and backend API abuse.

Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global medical innovator, today announced that it has entered into a definitive agreement pursuant to which Danaher Corporation (NYSE: DHR) (“Danaher”) will acquire Masimo for $180.00 per share in cash, representing a total consideration of $9.9 billion (the “Transaction”).

MindBridge, a leader in AI-powered financial intelligence, today announced the company’s global partnership with Genpact (NYSE: G), an agentic and advanced technology solutions company. Through this partnership, MindBridge’s AI capabilities will enhance the quality and depth of insights delivered to Genpact’s Enterprise Risk Consulting (ERC) clients worldwide.​

Wolfspeed, Inc. (NYSE: WOLF), a global leader in silicon carbide technology and manufacturing, today announced the appointment of Stefan Steyerl as vice president of sales, EMEA. Effective March 1, 2026, Steyerl will develop and execute Wolfspeed’s regional sales strategy, driving adoption of silicon carbide solutions across automotive, industrial, and energy markets as Wolfspeed accelerates the adoption of silicon carbide technology to expand its market footprint and deliver revenue growth across the region.

Jack in the Box Inc. (“Jack in the Box” or the “Company”) (NASDAQ: JACK), today announced that leading independent proxy advisory firm Institutional Shareholder Services (“ISS”) has recommended that Jack in the Box shareholders vote “FOR” all 10 of the Company’s director nominees, including David Goebel, Independent Chair of the Jack in the Box Board, on the WHITE proxy card in connection with the 2026 Annual Meeting of Shareholders (the “Annual Meeting”) scheduled to be held on February 27, 2026. Both ISS and Glass Lewis recommend shareholders vote “FOR” the Company’s shareholder rights plan.

Ray Therapeutics, a clinical-stage biotechnology company developing optogenetic gene therapies for vision restoration, today announced the appointment of Michael Murtagh as Chief Regulatory Officer. With more than 20 years of experience in regulatory affairs, Michael has led multiple Investigational New Drug Applications (INDs), Clinical Trial Applications (CTAs) and marketing applications across a range of indications, spanning therapeutic areas including oncology, cardiovascular disease, neurology and inborn errors of metabolism.

QuadSci, the most predictive and prescriptive AI for customer intelligence, secured an $8 million Series A financing round led by Crosslink Capital, with participation from Alumni Ventures, Correlation Ventures, and angel investors Shail Jain, Peter Gibson, Tom Roloff, and Rob Eberle.

HarbourVest Partners (“HarbourVest”), a global private markets investment firm with more than $146 billion in assets under management as of June 30, 2025, today announced the final close of its inaugural Private Equity Continuation Solutions (PECS) Fund, an investment vehicle focused on single asset continuation transactions that enable GPs to extend their ownership of high conviction portfolio companies.

Cinemo, a global leader and highly innovative one-stop-shop provider for fully integrated digital media products, partnered with Škoda to bring a native Spotify experience to the Škoda Enyaq models with software versions 4.x and 5.x and all Elroq models, offering drivers and passengers seamless access to music, podcasts and audiobooks directly from the vehicle’s infotainment system.

Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a drug discovery company developing breakthrough medicines through AI-enhanced computational chemistry, today announced that it will present preclinical and translational data from its novel salt-inducible kinase 2 (SIK2) inhibitor program in poster presentations at the 21st Congress of the European Crohn’s and Colitis Organisation (ECCO), taking place February 18-21, 2026, in Stockholm, Sweden.

Eagle Point Institutional Income Fund (the “Fund”) is pleased to announce the declaration of distributions on shares of the Fund’s 8.125% Series A Term Preferred Shares due 2029 (the “Preferred Shares”) as follows:

Venu Holding Corporation (“VENU”) (NYSE American: VENU), a developer, owner, and operator of upscale live entertainment venues and premium hospitality destinations, today announced it is launching a new video series designed to answer investor questions and share timely, high-level updates on the Company’s venue development and operational progress. The first episode was released today.

McLaren Health Care and its McLaren Heart & Vascular Institute have launched a first-of-its-kind cardiovascular screening program in Michigan to strengthen and expand its ability to identify patients’ risk for heart disease earlier and connect them with timely, appropriate care.

NImmune Biopharma (“NImmune”), a private late-stage precision inflammation and immunology (“I&I”) biopharmaceutical company, today announced that Executive Chairman, President and CEO Dr. Josep Bassaganya-Riera will be launching a new clinical program and business venture to develop NIM-1324 as its lead asset focused on inflammatory bowel disease (IBD), with follow-on I&I indications, including lupus and psoriasis.

Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, today announced management will participate in upcoming investor conferences in February and March, as follows:

Eagle Point Income Company Inc. (the “Company”) (NYSE: EIC, EICA, EICC) today is pleased to announce the declaration of distributions on shares of the Company’s common stock.

Eagle Point Credit Company Inc. (the “Company”) (NYSE: ECC, ECCC, ECC PRD, ECCU, ECCV, ECCW, ECCX) today announced financial results for the quarter and full year ended December 31, 2025 and certain additional activity through January 31, 2026 and declared distributions on shares of the Company’s common and preferred stock.

KnowBe4, the world-renowned platform that comprehensively addresses human and agentic AI risk management, today announced it has released a new white paper, “Security the Public Sector at Scale: How Unified Human Risk Management Drives Cyber Resilience,” which focuses on the U.S. public sector’s vulnerabilities to human risk.

Veritas Capital (“Veritas”), a leading technology investor, today announced $15.3 billion in total capital raised across The Veritas Capital Fund IX (“Fund IX”) and related investment vehicles.1 The close comes amid a pronounced slowdown in private equity fundraising, as many firms face extended timelines and reduced allocations. Securing $15.3 billion in this environment underscores investor conviction in Veritas’ differentiated strategy. The capital raised marks a meaningful increase relative to the Firm’s predecessor Flagship Fund, with Fund IX 40% larger than Fund VIII, which was itself 68% larger than Fund VII, reflecting sustained investor confidence in the strength and performance of the platform.

Paladin EnviroTech (“Paladin”), a technology-lifecycle partner that helps organizations recycle securely, compliantly, and without losing control of data or valuable materials, today announced the opening of its first Paladin Recycle Local satellite location in Laurel, Maryland. The new site addresses the long-overlooked “last mile” of e-waste recycling—where small and mid-sized organizations generate significant volumes of data-bearing equipment but lack access to secure, enterprise-grade end-of-life infrastructure—closing a critical gap in domestic recovery, security, and accountability.

Blue Bird Corporation (Nasdaq: BLBD), the leader in electric and low-emission school buses, has signed an agreement to acquire Girardin Group’s stake in the 50/50 Micro Bird joint venture, thereby, taking full ownership of the enterprise. Blue Bird will pay approx. $200 million for Girardin’s joint venture share, with 30% in cash and 70% in Blue Bird common stock. The transaction is expected to close in the first half of calendar year 2026, pending fulfillment of various closing conditions and regulatory approvals. A slide presentation is available on the BLBD IR website (https://investors.blue-bird.com/) with additional details.

Sentinel Global, a multi-stage venture capital firm investing in enterprise technology founders who are reshaping the systems underpinning global markets, today announced a major expansion of the firm, reuniting a senior investment team that invested in companies such as Affirm, DoorDash, Airbnb, Chainalysis, Databricks, Zoom, Uber, Snowflake and Coinbase, and expanding Sentinel Labs, the firm’s AI-powered research arm, which helps limited partners and founders translate emerging technologies into deployable strategies. The new firm expects to be in the market in 2026 as it prepares its next phase of growth.

DDC Enterprise Limited (NYSEAMERICAN: DDC) (“DDC” or the “Company”), a global Asian food platform and digital asset treasury company, today announced the acquisition of an additional 80 Bitcoin (“BTC”), bringing its corporate treasury to 2,068 BTC.

Work AI leader Glean today announced the latest generation of its AI Assistant, Glean Assistant, an expert agentic coworker designed to fundamentally redefine personal productivity with AI. With new features spanning real-time voice, on-brand slide generation, agent sandboxes for deeper analysis, enterprise actions, and proactive agent templates, Glean Assistant acts as a true AI partner, working alongside employees to enable better decisions, faster execution, and the ability to stretch beyond traditional roles without sacrificing quality or trust.

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,* today announced data presentations from its innovative HIV treatment and prevention portfolio and integrase inhibitor (INSTI)-led pipeline at the 33rd Conference on Retroviruses and Opportunistic Infections (CROI) in Denver, Colorado from 22-25 February.

BIOEMTECH, a developer of high-resolution PET and SPECT imaging systems for preclinical and translational research, today announced a strategic supply agreement with NorthStar Medical Radioisotopes (NorthStar) to secure a reliable supply and provide Actinium-225 (Ac-225) for use in preclinical studies conducted by BIOEMTECH customers.

Artis BioSolutions today announced the appointment of Dr. Kate Broderick, Ph.D., as Chief Scientific Innovation Officer, effective February 9, 2026. Dr. Broderick will lead scientific strategy, advocacy and innovation initiatives across the Artis platform, supporting the company’s mission to build an integrated ecosystem for the development and manufacturing of next-generation genetic medicines.

Bridgewater Bank today announced the opening of its new Lake Elmo branch, officially welcoming clients to its ninth location across the Twin Cities and marking an important milestone in the bank’s expansion of its east metro presence.

Gloo (Nasdaq: GLOO), a leading technology platform serving the faith and flourishing ecosystem, announced the company will participate in the upcoming Citizens JMP Technology Conference in San Francisco, California.

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced positive results from its Phase 1 confirmatory pharmacokinetic/pharmacodynamic (PK/PD) clinical trial evaluating RLYB116, the Company’s innovative, once-weekly, small volume, subcutaneously injected C5 inhibitor, in development for patients with complement-mediated diseases with its initial focus on immune platelet transfusion refractoriness (PTR) and refractory antiphospholipid syndrome (APS).

North Highland, the leading change and transformation consultancy, welcomes Nyla Beth Gawel as senior managing director. Gawel joins our practices focused on workforce and change strategy.